(VIANEWS) – Shares of Canopy Growth (NASDAQ: CGC) rose by a staggering 24.47% in 10 sessions from $0.47 at 2023-06-27, to $0.59 at 23:15 EST on Monday, after two successive sessions in a row of gains. NASDAQ is jumping 0.21% to $13,816.77, after two sequential sessions in a row of gains.
Canopy Growth’s last close was $0.59, 87.63% below its 52-week high of $4.77.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-4.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canopy Growth’s stock is considered to be overbought (>=80).
More news about Canopy Growth (CGC).
